Clinical Performance of Verofilcon A Toric Contact Lenses
This study is looking at how well Total30 Multifocal Toric contact lenses work for people who have presbyopia (age-related farsightedness) and astigmatism (a common vision problem). The goal is to see if these lenses are comfortable and if people who have worn reusable toric contact lenses before are happy to keep wearing Total30 Multifocal Toric lenses after one month. You can join if you are an adult between 18 and 40 years old, currently wear reusable silicone hydrogel toric contact lenses, and need reading glasses (+0.75 ADD or more). Your vision will be checked after one month to see how well the lenses are performing. The current status of this study is unclear.
- Study design
- This is an interventional study planning to enroll 32 participants. Participants will be refit into Total30 Multifocal Toric contact lenses.
- What's involved
- Participants will be refit into Total30 Multifocal Toric contact lenses and will be asked to rate their comfort while wearing them.
- Compensation
- Not stated in the trial record.
- Follow-up
- Visual acuity scores will be measured at 1 month.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Clinical Performance of Verofilcon A Toric Contact Lenses
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Visual acuity scores1 month
This will be a prospective study to understand if reusable silicone hydrogel toric CL wearers who are presbyopic can be successfully refit into Total30 MFT CLs VAS scores will be judged from -50 to positive 50 with positive numbers being more comfortable and 0 being neutral.